Companies / Santa Cruz Biotechnology / RXRβ (11-13) FITC
Santa Cruz Biotechnology

RXRβ (11-13) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG1; RXRβ Antibody (11-13) is an IgG1 κ mouse monoclonal RXR beta antibody (also designated RXRβ antibody) that detects the RXR beta protein of human origin by WB, IP, IF and ELISA. RXRβ Antibody (11-13) is available as both the non-conjugated anti-RXR beta antibody form, as well as multiple conjugated forms of anti-RXR beta antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Two families of retinoid receptors, RARs and RXRs, have been identified. Retinoic acid receptors (RARs) include RARα, RARβ and RARγ, each of which have a high affinity for all trans-retinoic acids and belong to the same class of nuclear transcription factors as thyroid hormone receptors, vitamin D3 receptor and ecdysone receptor. The ligand-binding domains of the RARs are highly conserved and RAR isoforms are expressed in distinct patterns throughout development and in the mature organism. Members of the retinoid X receptor (RXR) family, RXRα, RXRβ and RXRγ, are activated by 9-cis-RA, a stereo- and photo-isomer of all trans-RA that is expressed in vivo in both liver and kidney and may represent a widely used hormone. As is true for the RAR subfamily, the RXR receptors are closely related to each other both in their DNA-binding and ligand-binding domains and are encoded by separate genes at distinct chromosomal loci.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.